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Estimating the magnitude of treatment effects ha~ been recommended as a 
solution to the problems associated with conventional hypothesis testing. In com· 
parison to tradition statistical tests of treatment effectiveness. omega squared (w~) 
and related magnitude of effect statistics provide a graduated rather than a di· 
chotomous judgmental aid. index the strength of the relationship between treat-
ment and outcome. and are unaffected by aspects of statistical power related to 
sample size. Unfortunately. these correlational statistics also have characteristics 
that limit their interpretative value. The size and therefore the meaning of w: 
varies as a function of (a) the reliabilities of both the treatment and outcome 
variables. (b) the subject. treatment. and other independent variables included in 
the investigation. and (c) the formula used to calculate w~. The interpretation of 
w~ also depends upon the conceptual clarity of the treatment variables. Finally. 
comparisons between w>s are problematic due to the limited information avail-
able concerning their sampling distribution. Indeed. the uncritical use of w~ to 
assess the effectiveness of behavioral treatments may represent a solution that is 
as troublesome as the problems the statistic was intended to remedy. 
The evaluation of treatment outcome involves complex empirical and 
conceptual issues including the breadth, importance. and durability of 
performance changes; the cost and efficiency with which these changes 
are brought about; and consumers' satisfaction with these changes (see, 
for example, recent discussions by Hartmann, Roper. & Gelfand. 1977, 
and by Kazdin & Wilson, 1978). Despite the general appeal of these 
criteria, conclusions about behavioral interventions typically are more 
narrowly based on comparisons of treatment performance with one or 
more standards. These standards may include pre-treatment perfor-
mance, alternative or no-treatment performance. normative performance, 
or ideal performance. Whichever standards are employed, decisions in 
group-design behavioral treatment studies often are based on the results 
of conventional statistical tests of the differences between means. These 
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tests only reveal the probability that a comparison is due to chance alone. 
They fail to assess and may even obscure the importance of treatments 
(e.g., Kazdin. 1980). 
The inadequacies of these statistical tests (see Morrison & HenkeL 
1970) have provoked a number of writers to suggest alternative or supple-
mentary statistical procedures for evaluating treatment effectiveness. One 
class of supplementary procedures recommended by behavior therapists 
(e.g .. Mahoney. 1977) are those that index the proportion of variance 
accounted for by treatments (or by other manipulated or measured vari-
ables such as chronicity of the client's problem or clinical skill level of the 
therapist). Given the ubiquity of variability in outcome across indivicfuals. 
treatments that account for a substantial portion of the total outcome 
variance would be judged noteworthy or important. Conversely. treat-
ments that account for a minor portion of outcome variance would be 
viewed as inadequate or as less important. 
These variance accounting or magnitude of effects statistics range from 
the familiar squared correlation coefficient to the more exotic generaliz-
ability coefficient (Cronbach, Gieser, Nanda. & Rajaratnam. 1972). This 
paper will critically examine the utility of these procedures for assessing 
treatment effectiveness. While the focus is on omega squared (we). the 
most frequently discussed magnitude of effect statistic. the comments are 
generally applicable to the entire class of procedures. 
Calculating w2 
Traditionally. w2 has been used to estimate the importance of treat-
ments in a fixed-effects design from the ratio of two variances-the vari-
ance attributable to the treatment divided by the sum of all sources of 
variance in the design. In determining the effectiveness of social ski II 
training in a treatment-control post-test only design. the value of we 
equals the ratio of treatment variance to treatment plus error variance [we 
= a7t I ((J':t + (J'~)]. These variance components are obtained from formu-
las for the expected mean squares for the design and from the calculated 
values of the mean squares for treatment and for error (see Table 1). 
Computational illustrations of w2 for a variety of designs are given in 
Dodd and Schultz (1973), Dwyer (1974). Fleiss (1969). Freidman (1968). 
Gaebelein, Soderquist, and Powers (1976). Golding (1975). Hays (1963). 
and Vaughan and Corballis (1969). 
In more complex investigations. additional variance components are 
included in the denominator for we: furthermore. separate w2's can be 
calculated for each main and interactive effect included in the design. For 
example, in a study comparing systematic desensitization with no-treat-
ment for moderate as well as severe agoraphobics. variance components 
would be calculated for treatments, problem severity, treatments by prob-
lem severity, and error. Separate w2's could be computed to assess the 
proportion of variance due to treatment vs. no-treatment. moderate vs. 
severe problem behaviors. and the interaction between these two factors. 
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TABLE I 
ANOVA SUMMARY TABLE EXTENDED TO INCLUDE THE INFORMATION REQUIRED TO CALCULATE 
W 1 FOR ... TWO-GROUP. BETWEEN SUBJECTS DESIGN (n = 10 IN EACH GROUP) 
Source df MS E(MS) Variance Component 
Treatment k - 1 I 85.0 O"~ + n0"1 4.0 = (MS, - MSc)/nk .44 = 4.<)/(4.0 + 5.0) 
Error kin - I) = lR 5.0 O"~ 5.0 = MS,. 
These w2's would index the absolute, as well as the relative importance of 
these factors in accounting for treatment outcome. 
Advantages of w2 
In comparison to traditional hypothesis testing, w" and related statistics 
have three major advantages that recommend their use to behavioral 
researchers. First, w" indexes the strength of association between inter-
vention and outcome (or between any independent and dependent vari-
able). Second, instead of providing a dichotomous index of treatment 
success (significant vs. non-significant). w" provides a continuous measure 
of the extent of the relationship between treatment and outcome . The 
values of w2 range from .00 (indicating that none of the variance in 
outcome is due to treatment) to 1.00 (indicating that all of the outcome 
variance is due to treatment). Third , unlike conventional hypothesis tests. 
w2 is not systematically affected by aspects of statistical power related to 
sample size. As a consequence of these properties, a small value of w" 
would quickly expose a weak, though statistically significant treatment. In 
contrast, and perhaps more important for small-n behavior therapy re-
search, a large value of w2 would indicate that even a statistically non-
significant or borderline result represents a strong relationship between 
intervention and outcome. In such a case, an investigator may conclude 
that the treatment is worth further study. whereas the decision "non-
significant" stemming from conventional statistical testing may result in 
discarding a promising technique. Thus, w" may perform a valuable func-
tion in clarifying the meaning of both statistically significant and statisti-
cally non-significant outcomes. 
Limitations of w2 
While w2 has certain advantages that would appear to make it an attrac-
tive supplement to conventional hypothesis testing for evaluating behavio-
ral treatments, the value of we is affected by a variety of factors which may 
make its meaning unclear. These factors, many of which also affect the 
values of conventional testing procedures and familiar correlational tech-
niques, include the following: (a) the reliabilities of the treatment and 
outcome variables, (b) the specific design of the study. including the sub-
ject and treatment variables employed, and (c) the formula used to calcu-
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late <.0". Our discussion of these factors that limit the interpretive value of 
w2 does not include situations in which the statistical assumptions of w2 are 
violated. In fact, we assume that w2 is only calculated on data that meet 
basic ANOV A and hence w" statistical assumptions. 
Reliability. The value of w2 is affected by inconsistency in implementing 
treatment procedures and unreliability in measuring treatment outcome. 
These irregularities increase error variance and hence lower the value of 
measures ;f association such as w 2• The error-free values of related mag-
nitude of effect statistics are estimated by applying one of the correction 
for attenuation formulas (e.g., Cronbach et a!.. 1972; McNemar, 1969). 
These formulas permit researchers to make appropriate interpretations of 
magnitude of effects statistics when the reliability of the variables is 
known. Unfortunately, these formulas have not been applied to w2 to 
correct it for errors of measurement. If errors of im~lementation or mea-
surement are substantial, the uncorrected value of w- will seriously under-
estimate the importance of the treatment with which it is associated. If 
reliabilities are unknown or not corrected for. the meaning of w2 may be 
ambiguous. 
Design. The second problem shared by magnitude of effect statistics is 
that their value may be manipulated by altering the design of the study, 
that is, by changing SUbject, treatment, or other independent variables. 
We will illustrate this point with two examples: First. when the range of 
levels of an independent variable is modified: and second, when indepen-
dent variables are either added or deleted. 
The value of w" may be varied appreciably by altering the range of 
levels of the treatment variables included in the investigation (Dooling & 
Danks, 1974). Restricting the range of an independent variable may 
lower the value of w" for that variable whereas using only extreme levels 
of the variable may raise the value of w2 (Glass & Hakstian. 1969). 
Consider an experiment on the effects of desensitization on snake avoid-
ance. If the experiment is conducted three times. first on a sample of 
moderate and severe snake phobics, next on a sample of mild, moderate, 
and severe snake phobics, and finally on mild and severe snake phobics, 
then the ordering of the values for w2,s associated with severity of snake 
phobia in the three experiments would be: 
w2 (moderate vs. severe) ~ w: (mild vs. moderate vs. severe) ~ w2 (mild 
vs. severe). 
(We are assuming here that the relationship between the effect of desen-
sitization and severity of snake phobia is linear and homoscedastic.) In 
the first experiment, the range of severity values is restricted, and so w2 
for this factor is relatively small, while in the last experiment the range of 
values is most extreme, which results in the largest value of w2 for the 
severity factor. 
The value of w2 can also be changed by adding or deleting independent 
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variables. Because w~ is defined as the ratio of treatment variance to total 
variance , the addition of any independent variable that increases total 
variance will produce a decrease in w~ . Consider an investigation compar-
ing desensitization with no treatment for severe tests anxious subjects . If 
this study yielded a variance component for treatments equal to 5.0 and a 
variance component due to error equal to 2.0, the value of w" for treat-
ments would be 5.0/(5.0 + 2.0) = .71. If severity of test anxiety was added 
as another independent variable, with main and interactive variance com-
ponents equal to 4.0, then the w~ for treatment would be reduced to 
5.0/(5.0 + 2.0 + 4.0) = .45. While the addition of independent variables 
can produce a decrease in w", the control of variables typically prese'2t in 
the investigation can produce an increase in w". Consider adding a variable 
such as the degree of relaxation achieved during the desensitization train-
ing which was uncontrolled in the original e~ample. Assume that the por-
tion of the error component due to the main and interaction effects of 
degree of relaxation was equal to 1.0 and the portion of the error compo-
nent due to other uncontrolled factors was also equal to 1.0. If degree of 
relaxation was controlled in another study by using only subjects who could 
achieve some behavioral criterion of deep relaxation. then the error com-
ponent would be reduced to 1.0 and the w] for treatment would be 5.0/(5 .0 
+ 1.0) = .83. It can be seen from these examples that the value of w" 
associated with treatments depends on whether other relevant variables 
are controlled by being held constant or are allowed to vary in the treat-
ment groups. The effect of the presence or the absence of other variables 
on w2 thus adds additional ambiguity to the interpretation of this magni-
tude of effect statistic. 
Because the magnitude of w~ depends on the independent variables 
and their range of levels included in the investigation, w] cannot be safely 
generalized across studies in which these factors differ. In a fixed-effect 
design, w2 can only be generalized safely across experiments with identi-
cal independent variables and levels of these variables (Golding, 1975). 
Similarly , the results of a significant F-test in a fixed-effects design cannot 
be generalized to any investigation in which these variables and their 
levels differ. 
Calculation Formulas . Controversy still exists over the appropriate magni-
tude of effect statistic to use and over the correct formulas to use in 
calculating w2 if it is the statistic of choice. Glass and Hakstian (1969) 
trace the history of measures of association and mention several alterna-
tives to w2 including e2 (epsilon squared) (Cohen, 1965) and 1]2 (eta 
squared) (Friedman, 1968) .1 
Dwyer (1974) , in discussing form ulas for calculating w 2, argues that the 
'According to Fleiss (1969) depending on the design used. w' may under-estimate the 
relationship between the outcome and treatment variables. while t) and ,,' overestimate the 
relationship. However. Keselman (1975) reported that w' was the most accurate estimator 
of the population association when compared with t' and ,,' in a Monte Carlo study. 
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methods outlined by Vaughan and Corballis (1969) overestimate the vari-
ance components for certain designs and hence affect the value of w' 
involving these components . Gaebelein et al. (1976) showed that Dwyer 
was assuming that the interaction effect in a design with one random and 
one fixed effect (e .g., randomly sampled therapists and fixed treatment) 
must sum to zero over the fixed effect; Vaughan and Corballis did not 
make this assumption . Unfortunately, statisticians do not agree on which 
of these is the correct assumption to make in a mixed model (Kemp-
thorne, 1968; Peng, 1967; Searle, 1971). Since the formulas advocated by 
Dwyer (1974) and by Vau?han and Corballis (1969) may yield substan-
tially different values of W-, researchers must be careful to indicate , the 
specific formula used in their calculations. 
The preceding three factors may require caution in interpretation be-
cause of their direct effects on the value of w' . The following two issues-
conceptual clarity of the treatment variables and the unknown character-
istic~ of the w 2 sampling distribution-may also affect the interpretation 
of W-. 
Complexity of the Treatment Variable. The meaning of w' may be unclear 
when the treatment variable is complex and does not form a conceptual 
unit (Doolings & Danks , 1974; Glass & Hakstian, 1969). To make sense 
as a conceptual unit, a treatment variable should vary on a single dimen-
sion. Easily defined and understood treatment variables are ones such as 
the number of modeling trials or the length of exposure to phobic stimuli. 
More complex are treatment variables or factors that include a control 
condition plus any number of different complex technique conditions such 
as desensitization and participant modeling. Such variables differ on mul-
tiple dimensions, and the meaning of w 2 associated with treatment vari-
ables of this kind may be conceptually unclear. 
Sampling Variability . On occasion. two or more w"s may be compared to 
determine which one among a number of treatment variables are of 
greater importance in prOducing outcome. In making such comparisons . 
investigators should keep in mind that w' calculated on sample values is a 
statistic, not a parameter. Like other statistics. we is subject to sampling 
fluctuations. Unfortunately. the standard error and other characteristics 
of the sampling distribution for w 2 are not yet well understood. 2 Still less 
is known about the sampling distribution relevant to comparing two cor-
related w 2,s obtained from the same investigation. The difference be-
~Monle Carlo slUdies have provided some information regarding the sampling distribu-
tion of wI. These studies have reponed that the standard deviation of w: depended upon the 
magnitude of experimental effects. upon whether the variate was sampled from a normal or 
exponential distribution (Keselman . 1975) . and upon the sample size (Carroll & Nordholm. 
1975). For example . with n = IS. w~'s as large as .28 were found under null conditions . 
Thus. when the sa mple size does not allow for a good estimate of variance components . the 
power of the F-test is low and w" is also poorl y estimated. 
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tween w2,s might be evaluated by treating the w2's as r's and applying 
procedures that are appropriate for testing the difference between corre-
lation coefficients (McNemar, 1969, p. 157; Steiger. 1980). Because this 
approach provides only rough approximations of statistical significance 
when used with w 2, conclusions regarding the relative importance of treat-
ment variables based on the comparison of w2's should be made with 
caution. 
SUMMARY 
Magnitude of effects statistics such as w2 have clear advantages that 
recommend their use to applied behavioral researchers. They provide a 
graduated measure of the strength of the relationship between treatment 
and outcome that is independent of sample size. Thus. we and related 
statistics are important supplements to conventional hypothesis testing 
procedures for evaluating the importance of treatments. However. these 
magnitude of effects statistics have limitations that require behavioral 
researchers to exercise considerable caution when employing them. The 
value of w2 is subject to attenuation resulting from lack of reliability in 
either the treatment or outcome variables. The selection of treatment 
factors and levels within these factors which occur in fixed-effects designs 
makes w2 a poor estimate of the generalized degree of association. There 
are also disagreements among statisticians about the appropriate statistic 
to use to estimate magnitude of effects and about the correct formulas to 
use in calculating w 2• The poorly defined variables sometimes found in 
treatment research makes interpretation of w2 difficult. The sampling 
distribution of w2 has not been identified, so the statistic cannot be used 
inferentially. The number and seriousness of these problems forces us to 
conclude that the uncritical use of magnitude of effects statistics as a cure 
for the problems of conventional hypothesis testing methods of assessing 
treatment effectiveness may very well represent a remedy as troublesome 
as the original problems. 
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